|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Osteoporosis | |||||
| Aging | |||||
| 2 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Bone Diseases, Metabolic | |||||
| Musculoskeletal Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Vitamin D3 | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Cholecalciferol | |||||
| Ergocalciferols | |||||
| Vitamin D | |||||
| 5 | More general drug interventions related to this trial | ||||
| Bone Density Conservation Agents | |||||
| Growth Substances | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||
| Office of Dietary Supplements (ODS) | |||||